The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| TLRY | -6.33% | -78.33% | -26.35% | -91% |
| S&P | +15.06% | +95.03% | +14.29% | +62% |
Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.
The cannabis stock is up 20% this year, and that's a phenomenal performance by its standards.
Maybe it's best to cut your losses and move on.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $209.50M | 4.7% |
| Gross Profit | $53.54M | 41.3% |
| Gross Margin | 25.56% | 6.6% |
| Market Cap | $1.52B | 5.4% |
| Market Cap / Employee | $0.53M | 0.0% |
| Employees | 2.8K | 7.2% |
| Net Income | $1.51M | 104.4% |
| EBITDA | $4.69M | 111.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $264.83M | 29.1% |
| Accounts Receivable | $107.08M | 2.9% |
| Inventory | 282.8 | 7.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $291.79M | -16.3% |
| Short Term Debt | $31.96M | -19.8% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -67.71% | -62.8% |
| Return On Invested Capital | -36.89% | -13.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$10.86M | 74.2% |
| Operating Free Cash Flow | -$1.34M | 96.2% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.34 | 0.20 | 0.15 | 0.97 | 133.93% |
| Price to Sales | 1.40 | 0.81 | 0.51 | 1.76 | -4.46% |
| Price to Tangible Book Value | 2.10 | 1.12 | 0.71 | 1.98 | -27.81% |
| Enterprise Value to EBITDA | -12488.00 | 343.03 | 21.79 | 320.39 | -55.92% |
| Return on Equity | -7.3% | -31.1% | -88.3% | -85.6% | 1280.28% |
| Total Debt | $373.79M | $343.91M | $328.74M | $323.74M | -16.65% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
